Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Adjustments to Financial Statements

Microsoft Excel

Adjustments to Current Assets

DexCom Inc., adjusted current assets

US$ in thousands

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
As Reported
Current assets
Adjustments
Add: Allowance for doubtful accounts
After Adjustment
Adjusted current assets

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).


The analysis of the annual financial data reveals notable trends in the current assets and adjusted current assets over the five-year period ending December 31, 2022.

Current Assets
The current assets increased consistently from 1,699,500 thousand US dollars in 2018 to 3,684,400 thousand US dollars in 2021, indicating a growing asset base that may reflect enhanced liquidity or operational scale. In 2022, however, there was a slight decrease to 3,668,800 thousand US dollars compared to 2021, suggesting a plateau or minor contraction after several years of growth.
Adjusted Current Assets
The adjusted current assets followed a similar upward trajectory, starting at 1,706,700 thousand US dollars in 2018 and reaching a peak of 3,689,800 thousand US dollars in 2021. This line item also experienced a modest decline in 2022, settling at 3,676,100 thousand US dollars. The adjustments made to current assets appear to maintain a close correlation with the reported current assets, indicating consistency between the reported and adjusted figures throughout the period.

Overall, the data illustrates a sustained growth in liquidity-related assets from 2018 through 2021, with both reported and adjusted figures showing strong alignment. The slight decrease in 2022 may warrant further investigation to understand underlying causes, but it does not significantly offset the long-term growth trend observed.


Adjustments to Total Assets

DexCom Inc., adjusted total assets

US$ in thousands

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
As Reported
Total assets
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Add: Allowance for doubtful accounts
Less: Deferred tax assets2
After Adjustment
Adjusted total assets

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Deferred tax assets. See details »


Total assets
The total assets demonstrated a consistent upward trend over the five-year period. Starting at approximately $1.92 billion at the end of 2018, the assets grew steadily to reach about $5.39 billion by the end of 2022. Notably, the most significant increase occurred between 2019 and 2020, where total assets almost doubled, reflecting potential expansion or substantial capital investment during that period. Following this surge, asset growth continued at a moderate pace from 2020 to 2022.
Adjusted total assets
Adjusted total assets displayed a similar upward trajectory, albeit with some fluctuations relative to total assets. Beginning just under $2.0 billion in 2018, this figure increased to approximately $5.06 billion by the close of 2022. Interestingly, adjusted assets were consistently slightly higher than total assets through 2018 and 2019 but fell below total assets growth in 2020. Following 2020, adjusted assets maintained steady growth, closely trailing total assets but with a marginally lower increase rate by 2022.
Overall trends and implications
The continuous growth in both total and adjusted assets indicates an expanding asset base, which may suggest ongoing investments in operational capacity or strategic acquisitions. The substantial jump between 2019 and 2020 might reflect a pivotal event or strategic shift influencing the company’s balance sheet substantially. The narrowing gap between total and adjusted assets in more recent years could imply changes in the asset composition or accounting adjustments impacting reported figures.

Adjustments to Current Liabilities

DexCom Inc., adjusted current liabilities

US$ in thousands

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
As Reported
Current liabilities
Adjustments
Less: Deferred revenue, current
Less: Accrued warranty, current
After Adjustment
Adjusted current liabilities

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).


The analysis of the financial data over the five-year period reveals significant trends in the company's current liabilities. Both the reported and adjusted current liabilities display a consistent upward trajectory from 2018 to 2022.

Current Liabilities
The current liabilities have exhibited a pronounced increase, beginning at approximately 222,400 thousand US dollars in 2018 and rising each subsequent year, reaching 1,839,300 thousand US dollars by 2022. This represents more than an eightfold increase over the five years, indicating a substantial expansion in short-term obligations or potential working capital requirements.
Adjusted Current Liabilities
Similarly, the adjusted current liabilities follow the same increasing pattern, starting slightly lower than the reported current liabilities in 2018 at 212,700 thousand US dollars and climbing steadily to 1,816,400 thousand US dollars in 2022. The close proximity of adjusted figures to reported values suggests limited adjustments and confirms the overall upward trend.
Trend Implications
The progressive increase in current liabilities could imply growing operational scale or increased reliance on short-term financing. However, such a steep rise may also warrant closer scrutiny regarding liquidity management, as higher current liabilities could strain short-term financial stability if not matched by adequate current assets or cash flows.

Adjustments to Total Liabilities

DexCom Inc., adjusted total liabilities

US$ in thousands

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
As Reported
Total liabilities
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1
Less: Deferred tax liabilities2
Less: Deferred revenue
Less: Accrued warranty
After Adjustment
Adjusted total liabilities

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred tax liabilities. See details »


The financial data indicates a consistent upward trend in both total liabilities and adjusted total liabilities over the five-year period ending December 31, 2022.

Total liabilities
Total liabilities increased steadily from 1,252,700 thousand US dollars in 2018 to 3,259,900 thousand US dollars in 2022. This represents a substantial rise, more than doubling over the period. The most significant increase occurred between 2019 and 2020, where liabilities rose by approximately 952,600 thousand US dollars, followed by continued growth in subsequent years, though at a somewhat slower rate.
Adjusted total liabilities
Adjusted total liabilities exhibit a similar upward trajectory, starting at 1,301,897 thousand US dollars in 2018 and reaching 3,213,100 thousand US dollars in 2022. The adjusted figures closely mirror the total liabilities data, with slight variations in magnitude but the same overall trend of increasing liabilities each year.

Overall, the data suggests that the company has been increasing its liabilities consistently over time. This trend might reflect expansion activities, increased borrowing, or other financing strategies. The parallel movement of total and adjusted liabilities indicates the adjustments do not substantially deviate from the original data, reinforcing the reliability of the observed trend.


Adjustments to Stockholders’ Equity

DexCom Inc., adjusted stockholders’ equity

US$ in thousands

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
As Reported
Stockholders’ equity
Adjustments
Less: Net deferred tax assets (liabilities)1
Add: Allowance for doubtful accounts
Add: Deferred revenue
Add: Accrued warranty
After Adjustment
Adjusted stockholders’ equity

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Net deferred tax assets (liabilities). See details »


Stockholders’ equity trends
The stockholders’ equity showed a consistent increase from 2018 to 2021. It rose from $663,300 thousand in 2018 to a peak of $2,251,500 thousand in 2021. However, in 2022, there was a noticeable decline to $2,131,800 thousand, indicating a decrease after several years of growth.
Adjusted stockholders’ equity trends
The adjusted stockholders’ equity also followed an upward trajectory from 2018 to 2021, increasing from $680,100 thousand in 2018 to $2,057,000 thousand in 2021. Unlike stockholders’ equity, adjusted stockholders’ equity peaked in 2021 but experienced a sharper decline in 2022, falling to $1,844,700 thousand.
Comparison between stockholders’ equity and adjusted stockholders’ equity
Throughout the five-year period, adjusted stockholders’ equity was generally slightly higher than stockholders’ equity until 2020, after which stockholders’ equity exceeded the adjusted figure. The gap between the two metrics widened particularly in 2020 and 2021, then narrowed again in 2022. Both metrics exhibit similar growth patterns and downturns in 2022.
Summary of insights
The financial data indicates strong equity growth from 2018 through 2021, reflecting capital accumulation or retained earnings increases. The declines observed in 2022 for both stockholders’ equity and adjusted stockholders’ equity suggest potential challenges that might include losses, dividends, or other capital adjustments during that year. The parallel movement of both measures suggests consistent adjustments were applied throughout the period.

Adjustments to Capitalization Table

DexCom Inc., adjusted capitalization table

US$ in thousands

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
As Reported
Short-term finance lease liabilities
Current portion of long-term senior convertible notes
Long-term senior convertible notes
Long-term finance lease liabilities
Total reported debt
Stockholders’ equity
Total reported capital
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1
Add: Short-term operating lease liabilities2
Add: Long-term operating lease liabilities3
Adjusted total debt
Adjustments to Equity
Less: Net deferred tax assets (liabilities)4
Add: Allowance for doubtful accounts
Add: Deferred revenue
Add: Accrued warranty
Adjusted stockholders’ equity
After Adjustment
Adjusted total capital

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Short-term operating lease liabilities. See details »

3 Long-term operating lease liabilities. See details »

4 Net deferred tax assets (liabilities). See details »


The financial data presents a clear depiction of trends concerning the company's debt, equity, and overall capital structure over a five-year period ending in 2022.

Total Reported Debt
The total reported debt exhibited a steady upward trend, rising from approximately $1.02 billion in 2018 to over $2.03 billion by the end of 2022. The most significant increase occurred between 2019 and 2020, where debt surged by around 61%, reflecting potential financing activities or increased borrowing in that period.
Stockholders’ Equity
Stockholders’ equity expanded substantially from $663 million in 2018 to reach a peak of approximately $2.25 billion in 2021, representing a more than threefold increase. However, in 2022, equity showed a decline to about $2.13 billion, indicating a possible contraction or redistribution of equity resources after previous growth.
Total Reported Capital
Total reported capital, which sums debt and equity, followed an upward trajectory from roughly $1.68 billion in 2018 to just over $4.16 billion in 2022. The growth was particularly pronounced between 2019 and 2020, consistent with the increase in both debt and equity components, suggesting an overall expansion of the company's financing base.
Adjusted Total Debt
Adjusted total debt mirrored the pattern of reported debt, increasing from about $1.08 billion in 2018 to approximately $2.15 billion in 2022. This measure also showed substantial growth between 2019 and 2020, indicating adjustments did not materially alter the underlying upward trend in the company's debt levels.
Adjusted Stockholders’ Equity
Adjusted equity increased from $680 million in 2018 to a peak of $2.06 billion in 2021, before decreasing to roughly $1.84 billion in 2022. The decline in the latest period suggests potential adjustments such as revaluations or accounting changes that impacted the equity base, aligning with the trend observed in reported equity.
Adjusted Total Capital
Adjusted total capital rose from about $1.76 billion in 2018 to near $4 billion by the end of 2022. The rise was steady, though growth slowed slightly from 2021 to 2022, reflecting the moderated changes in both adjusted debt and equity.

Overall, the data demonstrates a significant expansion in the company's financial structure over the five years, with increases in debt and equity contributing to a larger capital base. The substantial rise in debt between 2019 and 2020, coupled with the growth in equity, highlights a period of aggressive financing and scaling. The slight decline in equity in 2022, both reported and adjusted, may warrant further examination for underlying causes such as market conditions, operational performance, or accounting adjustments. The consistency between reported and adjusted figures reinforces the reliability of the upward trend in the company's capital framework.


Adjustments to Revenues

DexCom Inc., adjusted revenue

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
As Reported
Revenue
Adjustment
Add: Increase (decrease) in deferred revenue
After Adjustment
Adjusted revenue

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).


Revenue Growth
Revenue exhibited a consistent upward trend over the five-year period, increasing from approximately 1,031,600 thousand USD in 2018 to 2,909,800 thousand USD in 2022. This represents nearly a threefold increase, indicating strong and sustained growth throughout the timeframe.
Adjusted Revenue
The adjusted revenue closely mirrors the reported revenue, with only minor discrepancies in reported values for each year. This alignment suggests that the adjustments made have minimal impact on the overall revenue figures. Adjusted revenue rose from approximately 1,031,300 thousand USD in 2018 to 2,920,700 thousand USD in 2022, maintaining the growth trajectory observed in the total revenue.
Year-over-Year Changes
The year-over-year increases are substantial and generally consistent. Notably, revenue increased by approximately 43% between 2018 and 2019, around 30% between 2019 and 2020, slightly more than 27% between 2020 and 2021, and approximately 19% between 2021 and 2022. Although growth rates slightly decelerate over time, overall expansion remains robust.
Insights
The steady increase in both reported and adjusted revenue suggests effective business expansion or increased market demand for the company’s products or services. The alignment between adjusted and reported revenue indicates transparency and minimal need for significant accounting adjustments affecting revenue recognition.

Adjustments to Reported Income

DexCom Inc., adjusted net income (loss)

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
As Reported
Net income (loss)
Adjustments
Add: Deferred income tax expense (benefit)1
Add: Increase (decrease) in allowance for doubtful accounts
Add: Increase (decrease) in deferred revenue
Add: Increase (decrease) in accrued warranty
Add: Other comprehensive income (loss), net of tax
After Adjustment
Adjusted net income (loss)

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Deferred income tax expense (benefit). See details »


The financial data reveals significant changes in profitability over the five-year period observed. The net income transitioned from a considerable loss in 2018 to consistent profitability from 2019 onward.

Net Income (Loss)
Initially, there was a large net loss of -127,100 thousand US dollars in 2018. However, the company achieved a net profit of 101,100 thousand US dollars in 2019, indicating a strong turnaround. This positive trend accelerated dramatically in 2020, with net income rising to 493,600 thousand US dollars. Although there was a decrease in 2021 to 154,700 thousand US dollars, net income rebounded again to 341,200 thousand US dollars in 2022, showing overall positive momentum despite the dip.
Adjusted Net Income (Loss)
Adjusted net income data parallels the net income trend but at somewhat lower values starting from 2019. The adjusted net income shifted from a loss of -131,800 thousand US dollars in 2018 to a profit of 100,100 thousand US dollars in 2019. This figure increased to 223,400 thousand US dollars in 2020, then declined slightly to 146,400 thousand US dollars in 2021 before recovering to 320,200 thousand US dollars in 2022. The adjustment appears to moderate the income figures but maintains the overall pattern of recovery and growth relative to the initial loss.

In summary, the period exhibits a robust recovery from initial losses, with substantial profitability improvements particularly evident in 2019 and 2020. Despite a temporary decline in 2021, profitability strengthened again in 2022. The adjusted net income values confirm the pattern of growth while reflecting a more conservative view on profitability. This trend suggests effective operational management and potentially improved financial health over the observed period.